As of Apr 21
| -0.23 / -0.91%|
The 6 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 26.50, with a high estimate of 29.00 and a low estimate of 25.00. The median estimate represents a +5.41% increase from the last price of 25.14.
The current consensus among 7 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.